RMRichard McNulty

Richard McNulty

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Richard McNulty has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnostic stewardship in emergency departments using the UNTIE framework: a stepped-wedge cluster randomised study protocol

    by Pramod Chandru, Naren Gunja, Simon Poon, James L Mallows, Khanh Nguyen, Richard McNulty, Armando Teixeira-Pinto, Clement Loy

    Introduction Pathology testing accounts for over half of non-labour costs in Australian Emergency Departments (EDs), yet up to one-fifth of tests are unnecessary. Despite national guidance from the Australasian College for Emergency Medicine (ACEM) and the Royal College of Pathologists of Australasia (RCPA), variation in test ordering persists across departments and across clinical presentations. The Unnecessary Tests in Emergency (UNTIE) study aims to evaluate whether audit and feedback using a novel indicator can reduce unnecessary pathology testing. Methods and analysis UNTIE is a multicentre, stepped-wedge cluster randomised trial conducted across five metropolitan EDs in New South Wales, Australia. All adult ED presentations that fall within the 29 clinical conditions covered by the 2023 ACEM–RCPA guideline will be included. Presentations were identified using routinely collected ED triage diagnoses. Because the ACEM–RCPA pathology guideline specifies clinical presentations rather than diagnostic codes, a mapping process was developed to align triage terms used in the electronic medical record with the guideline categories. Approximately 100 common triage diagnoses were reviewed by a panel of emergency physicians and mapped to the 29 eligible presentations. This mapping dictionary was used to automatically classify all ED encounters during data extraction. Ambiguous or unmapped triage terms were reviewed and assigned by consensus. The intervention comprises a multifaceted audit-feedback programme—combining local champions, education sessions, visual prompts and electronic dashboards. Two automated indicators will be generated for every eligible ED encounter: UNTIE-U (Unnecessary Testing Index) representing the proportion of tests performed but not recommended and UNTIE-N (Necessary Testing Index) representing the proportion of guideline-recommended tests performed. The primary outcome is change in UNTIE-U before and after intervention; the secondary outcome is change in UNTIE-N. Ethics and dissemination Ethics approval has been granted by the Western Sydney Local Health District Human Research Ethics Committee (HREC/17/WMEAD/274, 2022/STE03249). All analyses will use de-identified data. Findings will be disseminated through peer-reviewed publication, conference presentation and feedback to participating EDs. Trial registration number Australian New Zealand Clinical Trials Registry: ACTRN12623001130651, UTN: U1111-1297-0386

  • Open Access

    Paracetamol adducts following overdose treated with a shorter acetylcysteine infusion: findings from the NACSTOP 2 trial

    by Anselm Wong, Laura P. James, Richard McNulty, Naren Gunja, Andis Graudins

    Paracetamol protein adducts in the circulation are a specific biomarker of paracetamol oxidation, and a highly sensitive measure of potential hepatic injury following overdose. We performed an analytical sub-study of adducts during a clinical trial (NACSTOP2) of abbreviated (12 hour) versus control (20 hour) acetylcysteine to identify any signal of decreased antidotal effectiveness with shortened therapy. We measured adducts from a convenience sample of subjects enrolled in the randomised-controlled NACSTOP2 trial evaluating a 12-hour ("abbreviated"; 200 mg/kg over four hours, 50 mg/kg over 8 hours) vs 20-hour acetylcysteine regimen ("control"; 200 mg/kg over four hours, 100 mg/kg over 16 hours). Adducts were assayed using high-performance liquid chromatography with electrochemical detection. The median alanine transaminase 20 hours after the initiation of acetylcysteine were 13 U/L (IQR 10-25 U/L) in the abbreviated 12-hour regimen group (n = 29), compared to the control group 14 U/L (IQR 10-19 U/L; n = 28) (P = 0.46). Adduct concentrations after 20 hours post initiation of acetylcysteine were similarly low in both groups: median 0.18 µmol/L, (IQR 0.09-0.24 µmol/L) to the control 0.17 µmol/L (IQR 0.11-0.27), P = 0.43. In both the NACSTOP and NACSTOP 2 trials, adduct concentrations remained low in this selected cohort of low risk patients, supporting abbreviation of the acetylcysteine regimen. In selected low-risk patients, paracetamol adduct formation remained similarly low whether acetylcysteine was stopped after 12 hours or continued for the standard 20 hours.

  • Open Access

    A logical analysis of null hypothesis significance testing using popular terminology

    by Richard McNulty

    Null Hypothesis Significance Testing (NHST) has been well criticised over the years yet remains a pillar of statistical inference. Although NHST is well described in terms of statistical models, most textbooks for non-statisticians present the null and alternative hypotheses (H0 and HA, respectively) in terms of differences between groups such as (μ1 = μ2) and (μ1 ≠ μ2) and HA is often stated to be the research hypothesis. Here we use propositional calculus to analyse the internal logic of NHST when couched in this popular terminology. The testable H0 is determined by analysing the scope and limits of the P-value and the test statistic’s probability distribution curve. We propose a minimum axiom set NHST in which it is taken as axiomatic that H0 is rejected if P-value< α. Using the common scenario of the comparison of the means of two sample groups as an example, the testable H0 is {(μ1 = μ2) and [(\(\overline{x}\) 1 ≠ \(\overline{x}\) 2) due to chance alone]}. The H0 and HA pair should be exhaustive to avoid false dichotomies. This entails that HA is ¬{(μ1 = μ2) and [(\(\overline{x}\) 1 ≠ \(\overline{x}\) 2) due to chance alone]}, rather than the research hypothesis (HT). To see the relationship between HA and HT, HA can be rewritten as the disjunction HA: ({(μ1 = μ2) ∧ [(\(\overline{x}\) 1 ≠ \(\overline{x}\) 2) not due to chance alone]} ∨ {(μ1 ≠ μ2) ∧ [\((\overline{x}\) 1 ≠ \(\overline{x}\) 2) not due to (μ1 ≠ μ2) alone]} ∨ {( μ1 ≠ μ2) ∧ [( \(\overline{\boldsymbol{x}}\) 1 ≠ \(\overline{\boldsymbol{x}}\) 2) due to ( μ1 ≠ μ2) alone]}). This reveals that HT (the last disjunct in bold) is just one possibility within HA. It is only by adding premises to NHST that HT or other conclusions can be reached. Using this popular terminology for NHST, analysis shows that the definitions of H0 and HA differ from those found in textbooks. In this framework, achieving a statistically significant result only justifies the broad conclusion that the results are not due to chance alone, not that the research hypothesis is true. More transparency is needed concerning the premises added to NHST to rig particular conclusions such as HT. There are also ramifications for the interpretation of Type I and II errors, as well as power, which do not specifically refer to HT as claimed by texts.


  • Food‐induced methemoglobinemia: A systematic review

    by Richard McNulty, Nikhil Kuchi, Elena Xu, Naren Gunja

    Methemoglobinemia is a sporadic, potentially fatal disease of poor tissue oxygenation in which ferrous hemoglobin (Fe 2+ ) is oxidized to the ferric (Fe 3+ ) state, rendering it incapable of binding oxygen (O 2 ). Fortunately, it is diagnosable and treatable. Here, we present a systematic review of food‐induced methemoglobinemia. PubMed and Embase databases were searched using the term “methemoglobin*,” for articles up to December 31, 2020. Inclusion criteria were confirmed or probable cases of methemoglobinemia with an oxidant confirmed in food or body tissue samples, or the oxidant likely to have come from food. We found 97 articles describing 568 cases. Median age was 6 years (range: 2 weeks to 80 years). Median methemoglobin fraction was 30% ( n = 142). Oxidizing agents were predominantly nitrites and nitrates. The commonest type of presentation was children eating vegetables (30%), followed by accidental ingestions (27%), and meat curing misadventures (22%). Favism was found to result in mild methemoglobinemia, highest fraction reported was 15.8%. Of the 35 deaths, 32 were from accidental ingestions (91%). In some fatal cases, diagnosis was likely delayed or missed, and antidote was not administered. The majority of cases survived, even with severe methemoglobin levels of up to 89%, provided that methylene blue was administered. Treatment with methylene blue alone resulted in an average methemoglobin drop of 39.1% ( n = 22). Methemoglobinemia cases continue to occur due to accidental exposure, meat curing misadventures, and babies ingesting nitrate‐rich vegetables which have been inappropriately stored. Early recognition of the toxidrome, instituting antidote treatment, and notifying public health authorities are key to improved outcomes.


  • Utility of non‐contrast head computed tomography in poisoned patients

    by Richard McNulty, Lashnika Bandaranayake, Timothy Wong, Alex Garner, Farhan Tahmid, Emily Symes, Mohammad Mohammad, Mark Salter, Naren Gunja

    Objective: To investigate the utility of non‐contrast head computed tomography (CT) in poisoned patients.Methods: A retrospective cohort study of patients referred to a toxicology unit between August 2010 and December 2017. Our database yielded patients who underwent head CT at presentation to the ED. Pre‐specified information was compiled from the medical records.Results: There were 6261 presentations of which 1142 underwent head CT (17%). Median age was 41 years, and 437 (38%) were female. There were 492 (43%) recreational ingestions and 466 (41%) deliberate self‐poisonings. The commonest agents were sedatives 376 (33%) and opioids 282 (24%); 334 (29%) cases were intubated. Signs of head injury were found in 153 cases (13%) and focal neurological signs in 68 (6%). No acute pathology was reported in 884 head CTs (77%), chronic changes in 193 (17%) and incidental findings in 26 (2%). Acute pathology was found in 39 (4%) patients: 15 with hypoxic‐ischaemic injury, three infarctions, nine with intra‐cranial haemorrhage, 11 facial bone fractures and one retro‐bulbar haematoma. No patient required an immediate surgical intervention, and only one patient had a change to clinical treatment. Acute head CT pathology was associated with at least one of the following clinical features: need for intubation, signs of head injury, seizure, headache, and unexpected neurological signs.Conclusion: Non‐contrast head CT is a low‐yield investigation in patients presenting with poisoning. Consideration should be given as to whether the clinical presentation is consistent with the expected toxidrome and whether the patient would benefit from head CT.


  • Fewer adverse effects with a modified two-bag acetylcysteine protocol in paracetamol overdose

    by Richard McNulty, Jia Min Elizabeth Lim, Pramod Chandru, Naren Gunja

    Objective: Acetylcysteine (NAC), an effective antidote for paracetamol poisoning, is commonly associated with adverse reactions. This has been postulated to be related to the rapid initial infusion rate (150 mg/kg over 1 h) of the traditional three-bag protocol. We hypothesized that a slower rate would result in fewer adverse reactions. Our institution in Western Sydney moved to a modified two-bag protocol in February 2015 – first bag: 200 mg/kg over 4 h (50 mg/kg/h) and second bag: (100 mg/kg over 16 h). Methods: Data was extracted from our database on paracetamol overdoses treated with NAC from August 2010 to September 2016. We compared adverse reactions in patients receiving the modified two-bag protocol with a historical control (traditional three-bag regimen with initial bolus of 150 mg/kg/h). Results: Over the study period 1011 paracetamol poisonings presented to our toxicology service, of which 476 required NAC (three-bag = 313, two-bag = 163). Demographic characteristics of the two groups were similar. Fewer anaphylactoid reactions (itch, rash, and swelling) occurred using the two-bag regimen (14% versus 5%, p = .002), a relative reduction of 66%. Similarly, there were fewer prescriptions of anti-allergy medications in the two-bag group (11% versus 4%, p = .01). There was no difference in incidence of hepatotoxicity. Conclusions: Adverse reactions to NAC were less common with the two-bag regimen. These results add to the accumulating evidence that reducing the initial NAC infusion rate reduces the risk of adverse reactions.